Format

Send to

Choose Destination
See comment in PubMed Commons below
J Child Neurol. 2013 Jul;28(7):926-32. doi: 10.1177/0883073813484967. Epub 2013 Apr 22.

A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy.

Author information

1
Department of Pediatric Genetics, Hacettepe University, Ankara, Turkey. geutine@hacettepe.edu.tr

Abstract

GRID2 is a member of the ionotropic glutamate receptor family of excitatory neurotransmitter receptors. GRID2 encodes the glutamate receptor subunit delta-2, selectively expressed in cerebellar Purkinje cells. The phenotype associated with loss of GRID2 function was described only in mice until now, characterized by different degrees of cerebellar ataxia and usually relatively mild abnormalities of the cerebellum. This work describes for the first time the human phenotype associated with homozygous partial deletion of GRID2 in 3 children in one large consanguineous Turkish family. Homozygous deletion of exons 3 and 4 of GRID2 (94 153 589-94 298 037 bp) in the proband and similarly affected cousins, and heterozygous deletions in parental DNA were shown using Affymetrix® 6.0 single-nucleotide polymorphism array, confirmed by real-time polymerase chain reaction. The phenotype includes nystagmus, hypotonia with marked developmental delay in gross motor skills in early infancy followed by a static encephalopathy course with development of cerebellar ataxia, oculomotor apraxia, and pyramidal tract involvement.

KEYWORDS:

GRID2; cerebellar ataxia; deletion; excitatory neurotransmitter; glutamate; homozygous; intellectual disability

PMID:
23611888
DOI:
10.1177/0883073813484967
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center